Venezuela Pharmaceuticals & Healthcare Report Q2 2018
The pharmaceutical landscape will remain highly challenging for multinational drugmakers and domestic firms inVenezuela. With the country's economic, political and debt crises unlikely to abate in the near future, the poor businessenvironment will keep investment and productive capacity subdued over the short term at least. For multinational drugmakers, theywill remain incentivised to limit their activity in the country and this will continue to have a negative knock-on effect for healthcarespending and national medicine availability.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook